Benefit of Virtual Reality Headset Use on Apathy in Older Adults With Major Neurocognitive Disorders

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-01-03

Study Completion Date

2024-01-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to verify that virtual reality is tolerably compatible with apathetic pathologies in patients and residents with major neurocognitive disorders. The main questions it aims to answer are:

* Does virtual reality have an impact on symptoms of apathy in the elderly?
* Is virtual reality well tolerated by the elderly? Participants will benefit from a 3-session virtual reality headset program with a healthcare professional. They will have one session per week for 3 weeks. They will be observed by another professional, who will complete observation grids on apathy, engagement in activity and tolerance of the virtual reality headset.

There is not a comparison group: Researchers will compare the scores before and after the intervention: the participant will be his own control.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Usability of Virtual Reality in Subjects With Mild Cognitive Impairment or Alzheimer's Disease

NCT02176629

MCI Alzheimer's Disease

COMPLETED NA

Non-randomized Clinical Trial on Cognitive Stimulation With Virtual Reality in Patients With Mild Cognitive Impairment

NCT06977815

Mild Cognitive Impairment Cognitive Dysfunction Aging

RECRUITING NA

Assessment of Attentional and Executive Disorders in Multiple Sclerosis Using Techniques of Virtual Reality

NCT01805336

Relapsing-Remitting Multiple Sclerosis

COMPLETED NA

The Feasibility, Safety and Tolerability of VR-based Audiovisual Stimulation

NCT06234930

Healthy Aging Alzheimer's Disease

COMPLETED NA

Virtual Reality Cognitive Training for Older Adults With Mild Cognitive Impairment

NCT06392412

Mild Cognitive Impairment Older Adults

NOT_YET_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is a multicenter interventional exploratory study in two nursing homes and a geriatric long-term care service. Thirty patients will be included. They will be recruited from residents of the long-term care departments of two hospitals, and 4 nursing homes.

A pre- and post-intervention comparison will be made by assessing apathy using the apathy inventory and the neuropsychiatric inventory in the care team version. A comparison of participants' engagement will be carried out through ecological observation of the interventions. This will be objectivized by the Caregiver Interaction Behavior Scale (ECPAI) before the immersion program, and during the first and third virtual reality sessions. An ECPAI scale taken during a conventional animation prior to the program will establish a baseline state for the participant.

The main goal is to verify that virtual reality is tolerably compatible with apathetic pathologies in patients and residents with major neurocognitive disorders.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Apathy in Dementia Aged Virtual Reality Neurocognitive Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention

The participant will benefit from three immersion sessions with the virtual reality headset, either individually or in a group session, accompanied by a team member trained in the use of the headset (psychomotrician, occupational therapist, doctor, psychologist, facilitator). At each session, the scale of observed emotions and the cybermalaise questionnaire will be completed (T1, T2, T3). At sessions 1 (T1) and 3 (T3), the investigator will administer the ECPAI behavior scale.

Group Type EXPERIMENTAL

Casque Lumeen

Intervention Type DEVICE

Participants will take part in virtual reality sessions via headset. They will benefit from a before/after evaluation, and a 3-week intervention where they will have 1 virtual reality session per week.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Casque Lumeen

Participants will take part in virtual reality sessions via headset. They will benefit from a before/after evaluation, and a 3-week intervention where they will have 1 virtual reality session per week.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Persons over 65 years of age
* Persons living in nursing homes or hospitalized in long-term care
* Persons with correct vision or vision corrected by glasses
* People with no hearing problems, or with hearing loss corrected by a hearing aid
* Person with a major neurocognitive disorder
* Person with a Mini Mental State Examination (MMSE) cognitive score \<26
* Individuals with documented apathy

Exclusion Criteria

* Person with a history of epilepsy
* Persons wearing a pacemaker
* Person with open wounds of the face or skull
* Disabling headache or neck pain
* Person at the immediate end of life or in active palliative care
* Person with a contagious disease
* People who are bedridden or unable to get into a wheelchair
* Persons with severe neurological impairment
* Person with severe behavioral disorders endangering self or staff
* Persons unable to give oral consent

Minimum Eligible Age

65 Years

Maximum Eligible Age

110 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No